4 things to know about Pfizer’s $5.2 billion acquisition target Anacor By: MarketWatch May 16, 2016 at 14:48 PM EDT Pfizer is paying billions for a company whose flagship product has not yet been approved. Read More >> Related Stocks: Eli Lilly Gsk Plc ADR Pfizer